MedPath

Non-surgical Periodontal Therapy: Efficacy of re Treatment for Non-responding Sites.

Conditions
Non Responding Sites
Periodontal Therapy
Registration Number
NCT05297227
Lead Sponsor
University of Siena
Brief Summary

The current experimental protocol is a pre-post quasi-experimental design. A cohort of individuals will be enrolled progressively according to a screening record of periodontitis. They were treated with PMPR and Subgingival Instrumentation according to their diagnosis. After 3 months they will be re-evaluated, and non-responding sites (Ppd\>=4mm and bop+) will be scheduled for the second session of PMPR and SI. After 2 months they will be re-evaluated and clinical efficacy will be defined.

Detailed Description

The current experimental protocol is a pre-post quasi-experimental design. A cohort of individuals will be enrolled progressively according to a screening record of periodontitis. Once included, individuals will receive, by a calibrated examiner, a full-mouth periodontal chart, and accordingly, they will be treated in a multi-step approach, in accordance with the recent clinical guidelines. The treatment will consist of oral hygiene instruction and motivation, risk factor control, professional mechanical plaque removal (PMPR), and subgingival instrumentation (SI): it will be performed by two experienced operators. Thereafter, after 3 months, patients will be evaluated and a new periodontal chart will be performed. The presence of non-responding sites (Ppd\>4 and bop+) will be treated with the second session of PMPR plus Subgingival Instrumentation. After 2 months patients will be clinically evaluated and a full periodontal chart will be completed.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
63
Inclusion Criteria
  • unremarkable general health; age 18-80; minimum of 20 teeth; Periodontitis (Stage 1-4); no antibiotic intake in the previous 6 months;
Exclusion Criteria
  • Subgingival instrumentation in the previous 12 months
  • No antibiotic intake in the previous 3 months
  • A compromised medical condition requiring prophylactic antibiotic coverage
  • Pregnant/nursing
  • Ongoing drug therapy that might alter the clinical signs and symptoms of periodontitis

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of pocket closuresthrough study completition, 6 months

Proportion of pathological periodontal pockets (non responding site) that will be closed (Ppd \<5 and bop-) after the second instrumentation

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath